{"denoms":[{"counts":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"279"},{"groupId":"BG003","value":"278"},{"groupId":"BG004","value":"587"}],"units":"Participants"}],"groups":[{"description":"Osimertinib (AZD9291) 80 mg once daily (QD) with Carboplatin (AUC of 5 mg/mL/min \\[AUC5\\]) and Pemetrexed (500 mg/m2), both administered every 3 weeks (Q3W) for 4 cycles, followed by Osimertinib 80 mg once daily plus Pemetrexed maintenance (500 mg/m2) Q3W","id":"BG000","title":"Safety Run-In: AZD9291 + Carboplatin + Pemetrexed"},{"description":"Osimertinib (AZD9291) 80 mg once daily (QD) with Cisplatin (75 mg/m2) and Pemetrexed (500 mg/m2), both administered every 3 weeks (Q3W) for 4 cycles, followed by Osimertinib 80 mg once daily plus Pemetrexed maintenance (500 mg/m2) Q3W","id":"BG001","title":"Safety Run-In: AZD9291 + Cisplatin + Pemetrexed"},{"description":"Osimertinib (AZD9291) 80 mg in combination with pemetrexed (500 mg/m2) plus either cisplatin (75 mg/m2) or carboplatin (AUC5) on Day 1 of 21-day cycles for 4 cycles, followed by Osimertinib (AZD9291) 80 mg QD with Pemetrexed maintenance (500 mg/m2) Q3W","id":"BG002","title":"Randomized: AZD9291 + Chemo"},{"description":"Osimertinib (AZD9291) 80mg QD.","id":"BG003","title":"Randomized: AZD9291"},{"description":"Total of all reporting groups","id":"BG004","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"12.82","value":"62.4"},{"groupId":"BG001","spread":"8.36","value":"60.4"},{"groupId":"BG002","spread":"10.03","value":"61.0"},{"groupId":"BG003","spread":"10.57","value":"60.7"},{"groupId":"BG004","spread":"10.3","value":"60.9"}]}],"title":"Age (Years)"}],"description":"Age in Years at study entry","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"Years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"38"},{"groupId":"BG003","value":"44"},{"groupId":"BG004","value":"88"}],"title":"<50"},{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"136"},{"groupId":"BG003","value":"122"},{"groupId":"BG004","value":"270"}],"title":">=50-<65"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"82"},{"groupId":"BG003","value":"88"},{"groupId":"BG004","value":"179"}],"title":">=65-<75"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"23"},{"groupId":"BG003","value":"24"},{"groupId":"BG004","value":"50"}],"title":">=75"}],"title":"Age Group"}],"description":"Age Groups in Years at study entry","paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"173"},{"groupId":"BG003","value":"169"},{"groupId":"BG004","value":"361"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"106"},{"groupId":"BG003","value":"109"},{"groupId":"BG004","value":"226"}],"title":"Male"}],"title":"Sex"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"39"},{"groupId":"BG003","value":"29"},{"groupId":"BG004","value":"68"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"15"},{"groupId":"BG002","value":"239"},{"groupId":"BG003","value":"248"},{"groupId":"BG004","value":"517"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"2"}],"title":"Unknown or Not Reported"}],"title":"Ethnicity"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"5"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"}],"title":"Native Hawaiian or other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"11"},{"groupId":"BG003","value":"6"},{"groupId":"BG004","value":"17"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"179"},{"groupId":"BG003","value":"176"},{"groupId":"BG004","value":"377"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"74"},{"groupId":"BG003","value":"83"},{"groupId":"BG004","value":"165"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"13"},{"groupId":"BG003","value":"10"},{"groupId":"BG004","value":"23"}],"title":"Other"}],"title":"Race"}],"description":"Race","paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"108"},{"groupId":"BG003","value":"107"},{"groupId":"BG004","value":"231"}],"title":"Asian, not specified"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"71"},{"groupId":"BG003","value":"69"},{"groupId":"BG004","value":"146"}],"title":"Chinese"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"99"},{"groupId":"BG003","value":"100"},{"groupId":"BG004","value":"207"}],"title":"Other ethnic population (Non-Asian)"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"3"}],"title":"Missing"}],"title":"Ethnic Population"}],"description":"Ethnic population","paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"}],"populationDescription":"The Safety Run-In treatment arms are based on the Safety set, which includes all participants allocated to the safety run-in group of this study and who receive at least 1 dose of study treatment (Osimertinib, Cisplatin, Carboplatin, or Pemetrexed).\n\nThe Randomized treatment arms are based on the Full Analysis set, which includes all participants allocated to the randomized group of this study and who were randomized to a treatment arm."}